is that 34,000 million ton or 34 billion kg ?? Am I reading this right?
to quell rumors that $6.5 was inflated price by the secondary guys
Buyer will get the pipeline for $300M ... maybe it will be J&J since its dox patents are going away
1- CEO and some management to step down
2- Sell the company
They say the $2 cash might be at risk as those that bought at $6.5 say they were misled. LoL .. Over past 20 years I have invested, I have never seen privil clients get their money back in a secondary offering that went sour ... CYTR has $120M cash Aand market cap of $250M
1-over 100M cash
2-market cap of about $200M
3- A drug that fda allowed them to keep dosing until PFS stops !! this is big
Following deal will be announced
Full Settlement for $250M and at same time acquisition at $12 a share and if for any reason sales falls through, a break up fee of $100M
This will cap RVP lawyer's fee to 30% of $250M and we get $12 a share
above is pure speculation on my side ... I think above deal structures allows maximum RVP shareholder benefit, appearance that sale was not part of settlement, protects RVP if BDX backs off from deal, and puts RVP litigation cost to a defined limit.
i welcome others suggestions
they have over $100M cash and 50 million shares or about $200M market cap
what a gift .. I don't care about lawsuit. What I care about is cash, debt, the drug's chance of success, drugs sales potential and patents protecting sales
warrant holders do what is best for stock price because warrant holders are also shareholders. It is better for stock to do cashless as less stock is sold to public. Cash injected at $2.5 can always be injected at less dilution.
If warrants holder decide to cash out 100%, then they still prefer cashless
Either way you look at, it will be cashless, unless thye want to exercise and hold for long term which I doubt
is about 15 million (most likely all warrants will be exercised cashless) .. so about 3 times float already traded !!!!
earnings is expected to be bad due to lira .. outlook should get progressively better in 2014-2020 .. so, these are bottom prices, i think
-- around 85% of revenue is recurring
-- Short listed on several $10M a year bids ...
My take is each win could add $5M / year to bottom line (I think each win could pop pps by $5 a share)
-- they also said integration of OTI went quite well
am not sure about revenue impact, but for sure more visibility on this revenue stream ... passports security
03/07/2014 10:21:16 Bought 5000 RVP @ 3.5799 -17,909.49 ---
03/07/2014 13:00:48 Bought 5000 RVP @ 3.5799 -17,909.49 ---
03/07/2014 13:26:45 Bought 10000 RVP @ 3.58 -35,809.99 ---
i posted my concern on oxgn and exited quite a while ago
I am not a big player and currently like
LoL ... Don't get to hopeful .. There was 70k shares traded and I added 20k on Friday .. and I really don't have any inside clue .. i do think it is close though